MedPacto announced on the 14th that it will participate in the 'BIO Europe Spring' held in Basel, Switzerland from the 20th to the 22nd (local time).
BIO Europe Spring is the largest bio conference in Europe attended by global pharmaceutical and biotech companies as well as investors. Global big pharma companies such as Pfizer, Merck (MSD) in the US, Novartis, Sanofi, Roche, and biotech companies participate.
Following the 'JP Morgan Healthcare Conference (JPMHC)' held in San Francisco, USA in January, MedPacto plans to discuss joint development and technology transfer of new pipelines, including treatments for bone diseases, with global pharmaceutical companies at this conference as well.
A MedPacto official said, "Following JPMHC, we will hold partnering meetings with global pharmaceutical companies and discuss joint development and technology transfer of new pipelines, including treatments for bone diseases."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
